Related Experiment Videos
Japanese Orthopaedic Association 2019 Guidelines for osteonecrosis of the femoral head
Wataru Ando1, Takashi Sakai2, Wakaba Fukushima3
1Department of Orthopaedic Medical Engineering, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Insights
The 2019 Clinical Practice Guidelines for Osteonecrosis of the Femoral Head (ONFH) offer a decision-making tool for doctors and patients. These guidelines cover ONFH epidemiology, pathology, diagnosis, and treatment options.
Area of Science:
- Orthopedics
- Clinical Practice Guidelines
Background:
- Osteonecrosis of the Femoral Head (ONFH) is a significant orthopedic condition.
- The Japanese Investigation Committee (JIC) developed guidelines to address ONFH management.
Purpose of the Study:
- To provide a decision-making support tool for clinicians and patients regarding ONFH.
- To establish evidence-based recommendations for the diagnosis and treatment of ONFH.
Main Methods:
- Guidelines were developed following the Medical Information Network Distribution Service Handbook for Clinical Practice Guideline Development 2014.
- The development process involved defining background and clinical questions to guide practice.
Main Results:
- The guideline covers epidemiology, pathology, diagnosis, conservative therapy, and surgical treatments (bone transplantation/cell therapy, osteotomy, hip replacement).
- Twelve background and 13 clinical questions were addressed to inform clinical practice.
Conclusions:
- The 2019 ONFH guidelines serve as a valuable resource for physicians, researchers, and patients.
- These guidelines aid in the decision-making process for managing ONFH effectively.
Purpose:
The Clinical Practice Guidelines for Osteonecrosis of the Femoral Head (ONFH) 2019 Edition, written by the working group for ONFH guidelines of the Japanese Investigation Committee (JIC) for ONFH under the auspices of the Japanese Ministry of Health, Labour, and Welfare and endorsed by the Japanese Orthopaedic Association, were published in Japanese in October 2019. The objective of this guideline is to provide a support tool for decision-making between doctors and patients.
Methods:
Procedures for developing this guideline were based on the Medical Information Network Distribution Service Handbook for Clinical Practice Guideline Development 2014, which proposed an appropriate method for preparing clinical guidelines in Japan.
Results:
This clinical practice guideline consists of 7 chapters: epidemiology; pathology; diagnosis; conservative therapy; surgical treatment: bone transplantation/cell therapy; surgical treatment: osteotomy; and surgical treatment: hip replacement. Twelve background questions and 13 clinical questions were determined to define the basic features of the disease and to be addressed when deciding treatment in daily practice, respectively.
Conclusions:
The clinical practice guidelines for the ONFH 2019 edition will be useful for physicians, investigators, and medical staff in clinical practice, as well as for patients, during the decision-making process when defining how to treat ONFH.